Sankaranarayanan R - Search Results

1

Are sarcopenia and its individual components linked to all-cause mortality in heart failure? A systematic review and meta-analysis.

Prokopidis K, Triantafyllidis KK, Kechagias KS, Mitropoulos A, Sankaranarayanan R, Isanejad M. Prokopidis K, et al. Among authors: sankaranarayanan r. Clin Res Cardiol. 2023 Dec 12. doi: 10.1007/s00392-023-02360-8. Online ahead of print. Clin Res Cardiol. 2023. PMID: 38085294

2

Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study.

Tajik B, Voutilainen A, Sankaranarayanan R, Lyytinen A, Kauhanen J, Lip GYH, Tuomainen TP, Isanejad M. Tajik B, et al. Among authors: sankaranarayanan r. ESC Heart Fail. 2023 Aug;10(4):2354-2361. doi: 10.1002/ehf2.14392. Epub 2023 May 10. ESC Heart Fail. 2023. PMID: 37165564 Free PMC article.

3

Is sarcopenia an associated factor of increased administration of specific medications in patients with heart failure? A systematic review and meta-analysis.

Saied S, Prokopidis K, Adenaya A, Isanejad M, Sankaranarayanan R. Saied S, et al. Among authors: sankaranarayanan r. Front Cardiovasc Med. 2024 Jan 25;11:1293537. doi: 10.3389/fcvm.2024.1293537. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38333416 Free PMC article. Review.

4

Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis.

Prokopidis K, Morwani-Mangnani J, McDowell G, Lip GYH, Venturelli M, Sankaranarayanan R, Isanejad M. Prokopidis K, et al. Among authors: sankaranarayanan r. Eur Geriatr Med. 2024 Mar 8. doi: 10.1007/s41999-024-00950-x. Online ahead of print. Eur Geriatr Med. 2024. PMID: 38457043 Review.

5

Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.

Prokopidis K, Ishiguchi H, Jordan C, Irlik K, Nabrdalik K, Formiga F, Sankaranarayanan R, Lip GYH, Isanejad M. Prokopidis K, et al. Among authors: sankaranarayanan r. Aging Clin Exp Res. 2024 Mar 6;36(1):57. doi: 10.1007/s40520-024-02713-x. Aging Clin Exp Res. 2024. PMID: 38446241 Free PMC article.

6

What is the association of polypharmacy with frailty in heart failure? A systematic review and meta-analysis.

Prokopidis K, Testa GD, Veronese N, Dionyssiotis Y, McLean J, Walker LE, Sankaranarayanan R. Prokopidis K, et al. Among authors: sankaranarayanan r. J Frailty Sarcopenia Falls. 2024 Mar 1;9(1):51-65. doi: 10.22540/JFSF-09-051. eCollection 2024 Mar. J Frailty Sarcopenia Falls. 2024. PMID: 38444545 Free PMC article. Review.

7

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.

Cleland JGF, Kalra PA, Pellicori P, Graham FJ, Foley PWX, Squire IB, Cowburn PJ, Seed A, Clark AL, Szwejkowski B, Banerjee P, Cooke J, Francis M, Clifford P, Wong A, Petrie C, McMurray JJV, Thomson EA, Wetherall K, Robertson M, Ford I, Kalra PR; IRONMAN Study Group. Cleland JGF, et al. Eur Heart J. 2024 Apr 21;45(16):1410-1426. doi: 10.1093/eurheartj/ehae086. Eur Heart J. 2024. PMID: 38446126 Free PMC article. Clinical Trial.

8

Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure.

Ajay A, Rasoul D, Abdullah A, Lee Wei En B, Mashida K, Al-Munaer M, Ajay H, Duvva D, Mathew J, Adenaya A, Lip GYH, Sankaranarayanan R. Ajay A, et al. Among authors: sankaranarayanan r. Expert Opin Investig Drugs. 2023 Jul-Dec;32(12):1157-1170. doi: 10.1080/13543784.2023.2290064. Epub 2023 Dec 28. Expert Opin Investig Drugs. 2023. PMID: 38032188 Review.

9

Continuous infusion versus bolus injection of loop diuretics for acute heart failure.

Rasoul D, Zhang J, Farnell E, Tsangarides AA, Chong SC, Fernando R, Zhou C, Ihsan M, Ahmed S, Lwin TS, Bateman J, Hill RA, Lip GY, Sankaranarayanan R. Rasoul D, et al. Among authors: sankaranarayanan r. Cochrane Database Syst Rev. 2024 May 22;5(5):CD014811. doi: 10.1002/14651858.CD014811.pub2. Cochrane Database Syst Rev. 2024. PMID: 38775253 Review.

10

Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.

Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. Meher N, et al. Among authors: sankaranarayanan ra. Adv Healthc Mater. 2024 May 3:e2304618. doi: 10.1002/adhm.202304618. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38700450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

558 results

Search Page